Dadu R - Search Results

1

Acquired Secondary RAS Mutation in BRAF^V600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors.

Cabanillas ME, Dadu R, Iyer P, Wanland KB, Busaidy NL, Ying A, Gule-Monroe M, Wang JR, Zafereo M, Hofmann MC. Cabanillas ME, et al. Among authors: dadu r. Thyroid. 2020 Sep;30(9):1288-1296. doi: 10.1089/thy.2019.0514. Epub 2020 May 7. Thyroid. 2020. PMID: 32216548 Free PMC article.

2

Hyperchloremic metabolic acidosis following resuscitation of shock.

Gheorghe C, Dadu R, Blot C, Barrantes F, Vazquez R, Berianu F, Feng Y, Feintzig I, Amoateng-Adjepong Y, Manthous CA. Gheorghe C, et al. Among authors: dadu r. Chest. 2010 Dec;138(6):1521-2. doi: 10.1378/chest.10-1458. Chest. 2010. PMID: 21138891 No abstract available.

3

Gurgling breath sounds may predict hospital-acquired pneumonia.

Vazquez R, Gheorghe C, Ramos F, Dadu R, Amoateng-Adjepong Y, Manthous CA. Vazquez R, et al. Among authors: dadu r. Chest. 2010 Aug;138(2):284-8. doi: 10.1378/chest.09-2713. Epub 2010 Mar 26. Chest. 2010. PMID: 20348197

4

Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions.

Dadu R, Cabanillas ME. Dadu R, et al. Minerva Endocrinol. 2012 Dec;37(4):335-56. Minerva Endocrinol. 2012. PMID: 23235190 Free PMC article. Review.

5

Sorafenib in metastatic thyroid cancer: a systematic review.

Thomas L, Lai SY, Dong W, Feng L, Dadu R, Regone RM, Cabanillas ME. Thomas L, et al. Among authors: dadu r. Oncologist. 2014 Mar;19(3):251-8. doi: 10.1634/theoncologist.2013-0362. Epub 2014 Feb 21. Oncologist. 2014. PMID: 24563075 Free PMC article. Review.

6

Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.

Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Dadu R, et al. J Clin Endocrinol Metab. 2014 Jun;99(6):2086-94. doi: 10.1210/jc.2013-3588. Epub 2014 Mar 14. J Clin Endocrinol Metab. 2014. PMID: 24628550 Free PMC article.

7

Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer.

Blevins DP, Dadu R, Hu M, Baik C, Balachandran D, Ross W, Gunn B, Cabanillas ME. Blevins DP, et al. Among authors: dadu r. Thyroid. 2014 May;24(5):918-22. doi: 10.1089/thy.2012.0598. Epub 2014 Mar 17. Thyroid. 2014. PMID: 24635127 Free PMC article.

8

Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.

Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas ME. Dadu R, et al. Oncologist. 2014 May;19(5):477-82. doi: 10.1634/theoncologist.2013-0409. Epub 2014 Apr 14. Oncologist. 2014. PMID: 24733667 Free PMC article.

9

In reply.

Cabanillas ME, Dadu R, Lai SY. Cabanillas ME, et al. Among authors: dadu r. Oncologist. 2014 Aug;19(8):e4. doi: 10.1634/theoncologist.2014-0186. Epub 2014 Jul 22. Oncologist. 2014. PMID: 25052450 Free PMC article.

10

Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience.

Dadu R, Shah K, Busaidy NL, Waguespack SG, Habra MA, Ying AK, Hu MI, Bassett R, Jimenez C, Sherman SI, Cabanillas ME. Dadu R, et al. J Clin Endocrinol Metab. 2015 Jan;100(1):E77-81. doi: 10.1210/jc.2014-2246. J Clin Endocrinol Metab. 2015. PMID: 25353071 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page